UNIENTER91.50

Uniphos Enterprises Limited

· Chemicals
AnnualQuarterly₹ CrorePeersVINYLINDIASRDMcap ₹636 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations0.00.050.63.030.55.172.95.90.00.026.10.0
Other Income40.40.90.60.84.70.50.20.324.40.10.40.2
Total Income40.40.951.33.835.15.673.16.124.40.126.50.2
Expenses
+ Purchases of Stock-in-Trade0.00.050.53.030.25.172.55.80.00.025.90.0
+ Employee Benefit Expense0.30.30.30.30.30.30.40.30.30.40.40.5
+ Finance Costs0.00.00.00.00.11.20.00.00.00.00.00.0
+ Depreciation & Amortisation0.20.20.20.20.20.20.20.20.20.20.20.2
+ Other Expenses0.50.40.70.50.50.71.60.50.80.60.70.7
Total Expenses1.00.951.74.031.37.574.76.91.31.127.11.4
EBITDA-0.8-0.7-0.9-0.8-0.5-1.0-1.6-0.8-1.1-1.0-0.8-1.2
EBIT-1.0-0.9-1.1-0.9-0.7-1.2-1.8-1.0-1.3-1.1-1.0-1.4
Profit
PBT before Exceptional Items39.5-0.0-0.4-0.13.9-1.9-1.6-0.723.2-1.0-0.6-1.2
Pretax Income39.5-0.0-0.4-0.13.9-1.9-1.6-0.723.2-1.0-0.6-1.2
+ Current Tax0.1-0.00.20.00.0-0.10.00.00.00.00.10.0
Tax Expense0.1-0.00.20.00.0-0.10.00.00.00.00.10.0
Net Income39.4-0.0-0.6-0.13.9-1.9-1.6-0.723.2-1.0-0.7-1.2
+ Net Income — Continuing Ops39.4-0.0-0.6-0.13.9-1.9-1.6-0.723.2-1.0-0.7-1.2
+ Other Comprehensive Income-248.5-100.6-460.8401.6136.7-370.2537.478.94.9509.1-905.014.0
Total Comprehensive Income-209.1-100.7-461.4401.5140.5-372.0535.978.228.1508.1-905.712.8
Per Share
Basic EPS5.660.00-0.09-0.020.56-0.27-0.23-0.113.33-0.15-0.10-0.17
Diluted EPS5.660.00-0.09-0.020.56-0.27-0.23-0.113.330.00-0.10-0.17
Other Comprehensive Income — detail
+ Other Comprehensive Income537.478.94.9509.1-905.014.0
+ Items NOT to be Reclassified to P&L-280.6-113.6-520.3453.5168.4-423.6627.091.98.9579.4-946.615.0
+ Tax on Items NOT to be Reclassified89.613.04.070.3-41.51.0
+ Tax on Items NOT to be Reclassified — alt tag-32.1-13.0-59.551.931.7-53.5
Per Share — as-filed variants
Basic EPS — Continuing Operations5.660.00-0.09-0.020.56-0.27-0.23-0.113.33-0.15-0.10-0.17
Diluted EPS — Continuing Operations5.660.00-0.09-0.020.56-0.27-0.23-0.113.330.00-0.10-0.17
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period190.9185.21.6
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit0.00.00.10.00.30.10.40.10.00.00.20.0
Gross Margin %0.200.990.970.990.580.990.94
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)39.5-0.0-0.4-0.13.9-1.9-1.6-0.723.2-1.0-0.6-1.2
Net Income Adj (tax-effected)39.4-0.0-0.6-0.13.9-1.9-1.6-0.723.2-1.0-0.7-1.2
EPS Adj5.660.00-0.09-0.020.56-0.27-0.23-0.113.33-0.15-0.10-0.17
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.002.002.002.002.002.00
Paid Up Equity Capital13.913.913.913.913.913.913.913.913.913.913.913.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.